175 related articles for article (PubMed ID: 11801219)
21. Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.
Silva MC; Davoli-Ferreira M; Medina TS; Sesti-Costa R; Silva GK; Lopes CD; Cardozo LE; Gava FN; Lyroni K; Dias FC; Frade AF; Baron M; Nakaya HI; Figueiredo F; Alves-Filho JC; Cunha FQ; Tsatsanis C; Chevillard C; Cunha-Neto E; Hirsch E; Silva JS; Cunha TM
Nat Commun; 2018 Apr; 9(1):1513. PubMed ID: 29666415
[TBL] [Abstract][Full Text] [Related]
22. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet.
Soares MB; Pontes-De-Carvalho L; Ribeiro-Dos-Santos R
An Acad Bras Cienc; 2001 Dec; 73(4):547-59. PubMed ID: 11743602
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of chronic Chagas heart disease.
Marin-Neto JA; Cunha-Neto E; Maciel BC; Simões MV
Circulation; 2007 Mar; 115(9):1109-23. PubMed ID: 17339569
[TBL] [Abstract][Full Text] [Related]
24. Immunological tolerance and its breakdown in Chagas' heart disease: role of parasitokines.
Gao W; Luquetti AO; Pereira MA
Front Biosci; 2003 Jan; 8():e218-27. PubMed ID: 12456303
[TBL] [Abstract][Full Text] [Related]
25. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease.
Belotti G
Am Heart J; 1998 Mar; 135(3):550. PubMed ID: 9527756
[No Abstract] [Full Text] [Related]
26. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).
Tanowitz HB; Machado FS; Jelicks LA; Shirani J; de Carvalho AC; Spray DC; Factor SM; Kirchhoff LV; Weiss LM
Prog Cardiovasc Dis; 2009; 51(6):524-39. PubMed ID: 19410685
[TBL] [Abstract][Full Text] [Related]
27. Rapidly progressive course of Trypanosoma cruzi infection in mice heterozygous for hexamethylene bis-acetamide inducible 1 (Hexim1) gene.
Mascareno E; Gupta R; Martello LA; Dhar-Mascareno M; Salciccioli L; Beckles D; Walsh MG; Machado FS; Tanowitz HB; Haseeb MA
Microbes Infect; 2018 Jan; 20(1):25-36. PubMed ID: 28951318
[TBL] [Abstract][Full Text] [Related]
28. Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?
De Bona E; Lidani KCF; Bavia L; Omidian Z; Gremski LH; Sandri TL; de Messias Reason IJ
Front Immunol; 2018; 9():1842. PubMed ID: 30127792
[TBL] [Abstract][Full Text] [Related]
29. 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection.
Pavanelli WR; Gutierrez FR; Mariano FS; Prado CM; Ferreira BR; Teixeira MM; Canetti C; Rossi MA; Cunha FQ; Silva JS
Microbes Infect; 2010 Aug; 12(8-9):587-97. PubMed ID: 20381637
[TBL] [Abstract][Full Text] [Related]
30. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
[TBL] [Abstract][Full Text] [Related]
31. Views on the autoimmunity hypothesis for Chagas disease pathogenesis.
Kierszenbaum F
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):1-11. PubMed ID: 12770754
[TBL] [Abstract][Full Text] [Related]
32. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
Hernández M; Wicz S; Corral RS
Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
[TBL] [Abstract][Full Text] [Related]
33. The heavy chain variable segment gene repertoire in chronic Chagas' heart disease.
Grippo V; Mahler E; Elias FE; Cauerhff A; Gómez KA; Tentori MC; Ruiz A; Vigliano CA; Laguens RP; Berek C; Levin MJ
J Immunol; 2009 Dec; 183(12):8015-25. PubMed ID: 19933850
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response.
Trocoli Torrecilhas AC; Tonelli RR; Pavanelli WR; da Silva JS; Schumacher RI; de Souza W; E Silva NC; de Almeida Abrahamsohn I; Colli W; Manso Alves MJ
Microbes Infect; 2009 Jan; 11(1):29-39. PubMed ID: 19028594
[TBL] [Abstract][Full Text] [Related]
35. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of myocardial damage in Trypanosoma cruzi infection.
Andrade ZA
Ciba Found Symp; 1983; 99():214-33. PubMed ID: 6416769
[TBL] [Abstract][Full Text] [Related]
37. Chagas disease etiology: autoimmunity or parasite persistence?
Tarleton RL; Zhang L
Parasitol Today; 1999 Mar; 15(3):94-9. PubMed ID: 10322321
[TBL] [Abstract][Full Text] [Related]
38. Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin.
Abel LC; Kalil J; Cunha Neto E
Braz J Med Biol Res; 1997 Nov; 30(11):1305-8. PubMed ID: 9532238
[TBL] [Abstract][Full Text] [Related]
39. Human chronic chagasic cardiopathy: participation of parasite antigens, subsets of lymphocytes, cytokines and microvascular abnormalities.
de Lourdes Higuchi M
Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():263-7. PubMed ID: 10677730
[TBL] [Abstract][Full Text] [Related]
40. Where do we stand on the autoimmunity hypothesis of Chagas disease?
Kierszenbaum F
Trends Parasitol; 2005 Nov; 21(11):513-6. PubMed ID: 16125464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
